Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Analysis of a wild mouse promoter variant reveals a novel role for FcγRIIb in the control of the germinal center and autoimmunity.

Espéli M, Clatworthy MR, Bökers S, Lawlor KE, Cutler AJ, Köntgen F, Lyons PA, Smith KG.

J Exp Med. 2012 Nov 19;209(12):2307-19. doi: 10.1084/jem.20121752. Epub 2012 Oct 29.

PMID:
23109709
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

FcgammaRIIB as a modulator of autoimmune disease susceptibility.

Tarasenko T, Dean JA, Bolland S.

Autoimmunity. 2007 Sep;40(6):409-17. Review.

PMID:
17729034
[PubMed - indexed for MEDLINE]
3.

FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications.

Smith KG, Clatworthy MR.

Nat Rev Immunol. 2010 May;10(5):328-43. doi: 10.1038/nri2762. Review. Erratum in: Nat Rev Immunol. 2010 Sep;10(9):674.

PMID:
20414206
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

FcgammaRIIB, FcgammaRIIIB, and systemic lupus erythematosus.

Niederer HA, Clatworthy MR, Willcocks LC, Smith KG.

Ann N Y Acad Sci. 2010 Jan;1183:69-88. doi: 10.1111/j.1749-6632.2009.05132.x. Review.

PMID:
20146709
[PubMed - indexed for MEDLINE]
5.

Genetic variation, Fcγ receptors, KIRs and infection: the evolution of autoimmunity.

Espeli M, Niederer HA, Traherne JA, Trowsdale J, Smith KG.

Curr Opin Immunol. 2010 Dec;22(6):715-22. doi: 10.1016/j.coi.2010.10.003. Epub 2010 Nov 1. Review.

PMID:
21050737
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk